Nanoparticle News and Research

RSS
First biodegradable gene delivery system efficiently penetrates human airway mucus barrier of lung tissue

First biodegradable gene delivery system efficiently penetrates human airway mucus barrier of lung tissue

New method helps determine titanium nanoparticles in sunscreen products

New method helps determine titanium nanoparticles in sunscreen products

Elsevier, NCI implement two-way linking between research articles on ScienceDirect and datasets in caNanoLab

Elsevier, NCI implement two-way linking between research articles on ScienceDirect and datasets in caNanoLab

Sorrento, NantBioScience form joint venture to develop targeted therapies against cancer

Sorrento, NantBioScience form joint venture to develop targeted therapies against cancer

Immune Pharmaceuticals amends licensing agreement with Endo Pharmaceuticals

Immune Pharmaceuticals amends licensing agreement with Endo Pharmaceuticals

Scientists find way to create therapeutic heat to treat people suffering from chronic muscle pain

Scientists find way to create therapeutic heat to treat people suffering from chronic muscle pain

NDSU researcher awarded $1.35 million research grant to develop targeted treatment for colorectal cancer

NDSU researcher awarded $1.35 million research grant to develop targeted treatment for colorectal cancer

DGIST researchers set on creating microrobot-assisted procedure for dealing with blocked arteries

DGIST researchers set on creating microrobot-assisted procedure for dealing with blocked arteries

Nanoparticles packed with chemotherapy drug and coated with chitosan target cancer stem-like cells

Nanoparticles packed with chemotherapy drug and coated with chitosan target cancer stem-like cells

Angiography and MPI: an interview with Professor Mauro Magnani University of Urbino

Angiography and MPI: an interview with Professor Mauro Magnani University of Urbino

Immune Pharmaceuticals begins bertilimumab Phase II clinical trials in Bullous Pemphigoid, Ulcerative Colitis

Immune Pharmaceuticals begins bertilimumab Phase II clinical trials in Bullous Pemphigoid, Ulcerative Colitis

Near-infrared imaging techniques for visualization of cartilage tissue

Near-infrared imaging techniques for visualization of cartilage tissue

Experimental vaccine candidate can stimulate immune system activity to prevent HIV infection

Experimental vaccine candidate can stimulate immune system activity to prevent HIV infection

Researchers use different approaches to test ways to manipulate nanoparticles in medicine

Researchers use different approaches to test ways to manipulate nanoparticles in medicine

Florida Institute finalizes funding agreement with TransGenex Nanobiotech

Florida Institute finalizes funding agreement with TransGenex Nanobiotech

Experimental AIDS vaccine candidate stimulates immune system to block infection in animal model

Experimental AIDS vaccine candidate stimulates immune system to block infection in animal model

Scientists explain the existence of intrinsic chirality in ordinary nanocrystals

Scientists explain the existence of intrinsic chirality in ordinary nanocrystals

Researchers investigate how ingested nanoparticles may influence metabolic processes

Researchers investigate how ingested nanoparticles may influence metabolic processes

‘Unsurpassed protein SEC’: OMNISEC delivers accurate information with minimal sample

‘Unsurpassed protein SEC’: OMNISEC delivers accurate information with minimal sample

Study: Intravenous nutrition source may significantly reduce toxicity of platinum-based cancer drugs

Study: Intravenous nutrition source may significantly reduce toxicity of platinum-based cancer drugs

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.